pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Conditioning chemotherapy followed by AbTCR (anti-CD19/CD22)-T cell infusion
Phase 1 · small molecule · Diffuse Large B Cell Lymphoma (DLBCL)
Conditioning chemotherapy followed by AbTCR (anti-CD19/CD22)-T cell infusion for Diffuse Large B Cell Lymphoma (DLBCL) is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code XJTU1AF2025LSYY-461
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- active
- Trials
- 1